Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Claeysen

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
ACS Chemical Neuroscience|May 27, 2015
Serotonin: A New Hope in Alzheimer's Disease?Sylvie Claeysen, Joël Bockaert, Patrizia Giannoni
Journal of Visualized Experiments : Jove|September 17, 2014
Primary culture of mouse dopaminergic neuronsFlorence Gaven, Philippe Marin, Sylvie Claeysen
Current Opinion in Pharmacology|February 24, 2011
5-HT(4) receptors, a place in the sun: act twoJoël Bockaert, Sylvie Claeysen, Valérie Compan, et al.
Neuropharmacology|July 8, 2008
5-HT(4) receptors: history, molecular pharmacology and brain functionsJoël Bockaert, Sylvie Claeysen, Valérie Compan, et al.
Frontiers in Aging Neuroscience|July 3, 2020
Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's DiseasePatrizia Giannoni, Silvia Fossati, Elena Marcello, et al.
Frontiers in Aging Neuroscience|March 3, 2020
Peripheral Routes to Neurodegeneration: Passing Through the Blood-Brain BarrierPatrizia Giannoni, Sylvie Claeysen, Francesco Noe, et al.
The Journal of Biological Chemistry|November 21, 2002
A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL)Sylvie Claeysen, Lara Joubert, Michèle Sebben, et al.
International Review of Cytology|January 24, 2002
G protein-coupled receptors: dominant players in cell-cell communicationJoël Bockaert, Sylvie Claeysen, Carine Bécamel, et al.
Cell and Tissue Research|August 10, 2006
Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulationJoël Bockaert, Sylvie Claeysen, Carine Bécamel, et al.
Expert Opinion on Therapeutic Patents|May 14, 2020
Therapeutic modulators of the serotonin 5-HT<sub>4</sub> receptor: a patent review (2014-present)Caroline Lanthier, Patrick Dallemagne, Cédric Lecoutey, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
ACS Chemical Neuroscience|May 27, 2015
Serotonin: A New Hope in Alzheimer's Disease?Sylvie Claeysen, Joël Bockaert, Patrizia Giannoni
Journal of Visualized Experiments : Jove|September 17, 2014
Primary culture of mouse dopaminergic neuronsFlorence Gaven, Philippe Marin, Sylvie Claeysen
Current Opinion in Pharmacology|February 24, 2011
5-HT(4) receptors, a place in the sun: act twoJoël Bockaert, Sylvie Claeysen, Valérie Compan, et al.
Neuropharmacology|July 8, 2008
5-HT(4) receptors: history, molecular pharmacology and brain functionsJoël Bockaert, Sylvie Claeysen, Valérie Compan, et al.
Frontiers in Aging Neuroscience|July 3, 2020
Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's DiseasePatrizia Giannoni, Silvia Fossati, Elena Marcello, et al.
Frontiers in Aging Neuroscience|March 3, 2020
Peripheral Routes to Neurodegeneration: Passing Through the Blood-Brain BarrierPatrizia Giannoni, Sylvie Claeysen, Francesco Noe, et al.
The Journal of Biological Chemistry|November 21, 2002
A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL)Sylvie Claeysen, Lara Joubert, Michèle Sebben, et al.
International Review of Cytology|January 24, 2002
G protein-coupled receptors: dominant players in cell-cell communicationJoël Bockaert, Sylvie Claeysen, Carine Bécamel, et al.
Cell and Tissue Research|August 10, 2006
Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulationJoël Bockaert, Sylvie Claeysen, Carine Bécamel, et al.
Expert Opinion on Therapeutic Patents|May 14, 2020
Therapeutic modulators of the serotonin 5-HT<sub>4</sub> receptor: a patent review (2014-present)Caroline Lanthier, Patrick Dallemagne, Cédric Lecoutey, et al.
Pageof 6